First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

(2009) P. D. Lister et al.   CLINICAL MICROBIOLOGY REVIEWS

In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods

(2009) Marisa Almuzara et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

(2009) C.R. Hansen et al.   Journal of Cystic Fibrosis

Characterization of a Naturally Occurring Class D  -Lactamase from Achromobacter xylosoxidans

(2008) Y. Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Urinary tract infection due toAchromobacter xylosoxidans: Report of 9 cases

(2008) Daniel Tena et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES